Back to Search Start Over

First-line trastuzumab (H), oral vinorelbine (NVBo) and capecitabine (X) combination therapy for HER2-positive metastatic breast cancer (MBC): efficacy and safety in a multinational phase II study.

Authors :
Chan, A.
Ganju, V.
Becquart, D.
Conte, P.F.
Petruzelka, L.
Goedhals, L.
Gil Gil, M.
Bernardo, G.
Villanova, G.
Tubiana-Mathieu, N.
Source :
EJC Supplements; Feb2008, Vol. 6 Issue 7, p220-221, 2p
Publication Year :
2008

Details

Language :
English
ISSN :
13596349
Volume :
6
Issue :
7
Database :
Supplemental Index
Journal :
EJC Supplements
Publication Type :
Academic Journal
Accession number :
32054554
Full Text :
https://doi.org/10.1016/S1359-6349(08)70894-2